52Indexed trials
Market Rank #34 · Evidence Tier A
Singapore
Neuroscience Intelligence
Singapore neuroscience intelligence: 52 indexed trials, 47 institutions, research score 31.71.
13Recruiting
47Research institutions
31.7Research score
Evidence profile
31Sponsors
14Disease areas
0Institution works
0Institution citations
Evidence signals
Research score 31.7 · Data confidence 100.00 · Evidence 31.7
Data confidence measures presence of evidence layers, not a probability of success. Scores are comparative decision-support signals, not guaranteed market size or commercial outcomes.
Leading disease areas
alzheimers12trials
stroke8trials
autism6trials
parkinsons5trials
dementia_other3trials
other_neurology3trials
depression3trials
epilepsy3trials
neuro_oncology2trials
other_psychiatry2trials
Leading indexed sponsors
Merck Sharp & Dohme LLC5trials
National University Hospital, Singapore4trials
National University of Singapore3trials
National Neuroscience Institute3trials
National Healthcare Group, Singapore3trials
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.3trials
Institute of Mental Health, Singapore3trials
Eisai Inc.2trials
Hoffmann-La Roche2trials
Singapore General Hospital2trials